Biotech Venture Funding Surges | Chemical & Engineering News
Volume 91 Issue 30 | p. 19 | Concentrates
Issue Date: July 29, 2013

Biotech Venture Funding Surges

Department: Business
Keywords: venture capital, biotech

Venture capital investment in the biotech industry surged in the second quarter of 2013 compared with the first quarter of the year, according to a new report from PricewaterhouseCoopers and the National Venture Capital Association. Although the number of deals rose just 4% to 103, the total amount invested grew 41% to $1.3 billion. Moreover, 33 companies in the life sciences sector, which encompasses biotech and medical devices, scored venture capital funding for the first time, up from 22 companies in the first quarter of 2013. “Life sciences investment is poised for a slow and steady recovery,” notes NVCA President Mark Heesen.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment